| Annual Financials | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
Revenue  | 58 | 74 | 78 | 69 | 62 | 0 |
| Expenses | 50 | 62 | 74 | 56 | 51 | 0 |
| EBITDA | 8 | 12 | 5 | 13 | 11 | 0 |
| Operating Profit % | 13 % | 16 % | 5 % | 18 % | 18 % | 0 % |
| Depreciation | 4 | 4 | 4 | 5 | 6 | 0 |
| Interest | 7 | 8 | 6 | 6 | 6 | 0 |
| Profit Before Tax | -4 | 1 | -6 | 2 | 0 | 0 |
| Tax | 0 | 1 | -1 | 0 | -0 | 0 |
| Net Profit | -4 | 0 | -6 | 2 | 0 | 0 |
| EPS in ₹ | -1.62 | 0.02 | -2.21 | 0.81 | 0.10 | 0.00 |
Cian Healthcare
Cian Healthcare
4.77
+0.09
(1.92%)
Market Cap
11.90 Cr
EPS
0.10
PE Ratio
47.70
Dividend Yield
0.00 %
Industry
Healthcare52 Week High
5.65
52 Week Low
2.97
PB Ratio
0.21
Debt to Equity
1.01
Sector
Pharmaceuticals
Investment Returns
In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Company News
View All News
The Resolution Professional of Cian Healthcare Limited, Mr. Roshen Chordiya, has re-appointed M/s Suraj Lahoti & Associates as the Cost Auditor for financial year 2025-2026. The company is currently undergoing Corporate Insolvency Resolution Process (CIRP), which was restored following an order dated August 14, 2024, by the National Company Law Tribunal. M/s Suraj Lahoti & Associates is a cost accounting firm with over 8 years of professional experience, specializing in cost audit, management consultancy, and compliance certification across industries including automobiles, chemicals, real estate, and steel.
Cian Healthcare's Committee of Creditors Holds 14th Meeting, Votes on Resolution Plan AmendmentsSep 12, 2025
Cian Healthcare Limited held its 14th Committee of Creditors meeting on September 12, 2025, as part of its ongoing Corporate Insolvency Resolution Process. The meeting covered process updates from the Resolution Professional, noted the revised creditor list, and reviewed minutes from the previous meeting held on June 21, 2025. The Committee noted the company's audited financial results for the half-yearly and financial year ended March 31, 2025, along with audit reports from statutory auditors SSRCA & Co. Key voting matters included approval of amendments to accounting treatment clauses in Mr. Pradeep Kumar Jain's resolution plan, ratification of CIRP costs incurred from August 15-31, 2025, and approval of inter se adjustment in amounts proposed for operational creditors. The Committee also noted the extension of the company's AGM for FY 2024-25.
Cian Healthcare Limited provided an update on its Corporate Insolvency Resolution Process. The company's resolution plan, which was approved by the Committee of Creditors in a meeting dated May 9, 2025, was heard by the National Company Law Tribunal Mumbai Bench. The next hearing for consideration and approval of the resolution plan is scheduled for August 22, 2025. The resolution plan was submitted to NCLT Mumbai Bench-VI on May 23, 2025. The company stated it will continue to keep stakeholders and regulatory authorities informed of further material developments.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,586.70 | #1 3,80,702.50 | 33.18 | #1 54,729.00 | 9.71 | #1 10,980 | -19.84 | 51.86 | |
5,689.50 | 1,51,038.30 | 65.50 | 9,712.00 | 18.67 | 2,191 | 26.74 | 36.39 | |
1,499.40 | 1,21,107.70 | 22.45 | 28,409.50 | 7.12 | 5,291 | 9.88 | 38.89 | |
3,561.00 | 1,20,520.40 | 59.72 | 11,539.40 | 6.99 | 1,911 | 19.91 | 42.61 | |
1,253.10 | 1,04,580.10 | #1 18.40 | 33,741.20 | 16.73 | 5,725 | 1.26 | 46.51 | |
2,482.90 | 1,02,476.40 | 54.18 | 12,744.20 | #1 20.90 | 2,007 | -18.14 | 44.66 | |
975.00 | 98,107.80 | 21.07 | 23,511.00 | 18.55 | 4,615 | 2.60 | 50.50 | |
1,919.80 | 87,676.40 | 23.72 | 22,909.50 | 13.74 | 3,306 | #1 51.64 | 46.16 | |
5,433.00 | 64,959.70 | 28.53 | 13,458.30 | 3.70 | 2,216 | 21.39 | 61.31 | |
1,090.00 | 63,307.40 | 18.84 | 32,345.60 | 9.43 | 3,484 | -10.24 | 53.78 |
Forecast
Actual
Growth Rate
Revenue Growth
-10.26 %
Net Income Growth
-85.00 %
Cash Flow Change
142.98 %
ROE
-87.54 %
ROCE
-23.79 %
EBITDA Margin (Avg.)
-3.14 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 | 2022 | 2023 | 2024 |
| Total Assets | 157 | 157 | 166 | 161 | 161 |
| Fixed Assets | 39 | 37 | 50 | 45 | 39 |
| Current Assets | 54 | 63 | 79 | 74 | 72 |
| Capital Work in Progress | 25 | 26 | 13 | 14 | 15 |
| Investments | 5 | 0 | 0 | 0 | 0 |
| Other Assets | 87 | 95 | 103 | 102 | 107 |
| Total Liabilities | 157 | 157 | 166 | 161 | 161 |
| Current Liabilities | 49 | 58 | 70 | 65 | 66 |
| Non Current Liabilities | 50 | 41 | 41 | 38 | 37 |
| Total Equity | 58 | 58 | 56 | 58 | 58 |
| Reserve & Surplus | 35 | 35 | 31 | 33 | 33 |
| Share Capital | 23 | 23 | 25 | 25 | 25 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 |
| Net Cash Flow | 1 | -1 | -1 | 0 | -0 |
| Investing Activities | -27 | 3 | 1 | 3 | -2 |
| Operating Activities | -7 | 6 | 9 | 5 | 12 |
| Financing Activities | 36 | -10 | -11 | -7 | -10 |
Share Holding
| % Holding | Mar 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Sept 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Mar 2025 |
| Promoter | 70.89 % | 70.89 % | 0.00 % | 66.26 % | 66.26 % | 66.26 % | 51.85 % | 49.62 % | 27.10 % | 27.10 % | 27.10 % | 27.10 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.79 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 17.48 % | 18.09 % | 0.00 % | 23.77 % | 23.95 % | 24.00 % | 41.88 % | 41.08 % | 55.78 % | 56.59 % | 59.23 % | 63.56 % |
| Others | 11.62 % | 11.02 % | 100.00 % | 9.97 % | 9.80 % | 8.95 % | 6.27 % | 9.30 % | 17.12 % | 16.31 % | 13.67 % | 9.34 % |
| No of Share Holders | 361 | 385 | 396 | 392 | 424 | 418 | 454 | 672 | 880 | 831 | 1,088 | 1,501 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 08 Oct 2024 |  Annual General Meeting | NA | 08 Oct 2024 | 5.46 | 4.96 |
Announcements
Closure of Trading Window
1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Change in Management10 days ago
10 days agoCorporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Change in ManagementSep 11, 2025
Sep 11, 2025Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsSep 10, 2025
Sep 10, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Sep 03, 2025
Sep 03, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 22, 2025
Aug 22, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 06, 2025
Aug 06, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Aug 05, 2025
Aug 05, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jul 16, 2025
Jul 16, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Jul 14, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jul 01, 2025
Jul 01, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsJun 24, 2025
Jun 24, 2025Financial Results For Year Ended 31/03/2025Jun 19, 2025
Jun 19, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)Jun 05, 2025
Jun 05, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMay 30, 2025
May 30, 2025Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsMay 28, 2025
May 28, 2025Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)May 24, 2025
May 24, 2025Initiation Of CIRP Against Dr. Smiths Biotech Private Limited (CIN: U24246PN2015PTC154818) A Wholly Owned Subsidiary Of The CompanyMay 24, 2025
May 24, 2025Corporate Insolvency Resolution Process (CIRP)-Filing of Resolution plan with TribunalMay 24, 2025
May 24, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMay 09, 2025
May 09, 2025Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018 And SEBI Operational Circular No. SEBI/HO/DDHS/P/CIR/2021/613 Dated August 10 2021.Apr 28, 2025
Apr 28, 2025Clarification Letter For Technical Error For Filing Form INC-22 With Respect To Change In Registered Office Of The Company With The MCA Portal.Apr 19, 2025
Apr 19, 2025Reconciliation Of Share Capital Audit Report Under Regulation 76 Of SEBI (Depositories And Participants) Regulations 2018.Apr 19, 2025
Apr 19, 2025Structured Digital Database (SDD) Compliance Certificate
Apr 19, 2025
Apr 19, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 12, 2025
Apr 12, 2025Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations 2011 For The Financial Year Ended 31St March 2025.Apr 07, 2025
Apr 07, 2025Results - Half Yearly Financial Statements For 30Th September 2024.Apr 03, 2025
Apr 03, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 29, 2025
Mar 29, 2025Closure of Trading WindowMar 27, 2025
Mar 27, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 26, 2025
Mar 26, 2025Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsMar 22, 2025
Mar 22, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 17, 2025
Mar 17, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 13, 2025
Mar 13, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsMar 07, 2025
Mar 07, 2025Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsMar 06, 2025
Mar 06, 2025Appointment Of Resolution ProfessionalFeb 22, 2025
Feb 22, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsFeb 22, 2025
Feb 22, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Feb 20, 2025
Feb 20, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsFeb 13, 2025
Feb 13, 2025Announcement under Regulation 30 (LODR)-Change in Registered Office AddressJan 31, 2025
Jan 31, 2025Appointment Of Transaction AuditorJan 31, 2025
Jan 31, 2025Announcement under Regulation 30 (LODR)-Change in ManagementJan 31, 2025
Jan 31, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsJan 31, 2025
Jan 31, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsJan 31, 2025
Jan 31, 2025Intimation Of Appointment Of Internal AuditorJan 31, 2025
Jan 31, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jan 31, 2025
Jan 31, 2025Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of CreditorsJan 25, 2025
Jan 25, 2025Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of CreditorsJan 21, 2025
Jan 21, 2025Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/sJan 21, 2025
Jan 21, 2025Technical Indicators
RSI(14)
Overbought 90.73
ATR(14)
Less Volatile 0.08
STOCH(9,6)
Overbought 100.00
STOCH RSI(14)
Overbought 100.00
MACD(12,26)
Bullish 0.08
ADX(14)
Very Strong Trend 56.45
UO(9)
Bearish 97.38
ROC(12)
Uptrend And Accelerating 25.20
WillR(14)
Overbought 0.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
